About EP Vantage

EP Vantage’s experienced editorial team consists of:

Lisa Urquhart, Editor

A Journalist with over 11 years experience, Lisa joined EP Vantage after spending seven years at the Financial Times, most recently as Biotechnology Correspondent. Lisa generated a number of exclusives during her time at the FT, including Barr's $2.2bn take over of Pliva. This experience has given Lisa a sound grounding in producing proprietary articles on the financial and pharmaceutical markets.

Email: lisau@epvantage.com

Christian Glennie, Senior Editorial Analyst

Christian joined EP Vantage from EvaluatePharma, where he worked as an analyst for seven years, developing extensive and in-depth knowledge of the pharmaceutical industry. Previously responsible for generating forecast models for over 60 pharma and biotech companies, Christian provides analysis and insight for EP Vantage content.

Email: christiang@epvantage.com

Amy Brown, Senior Reporter

Amy joined EP Vantage from Thomson Financial News, where she covered the European pharmaceutical and biotechnology sectors for several years. She has extensive experience working as a financial journalist, working for companies including Bloomberg News, and has been a contributor to publications such as Corporate Financier.

Email: amyb@epvantage.com

Jonathan Gardner, Reporter

Jonathan was previously a freelance journalist on a number of healthcare titles including Elsevier Global Medical News. Prior to this he was communications manager at US publication, Health Affairs Journal and bureau chief for Modern Healthcare magazine. Jonathan brings with him a wealth of experience in both the US primary healthcare market and regulatory affairs.

Email: jonathang@epvantage.com